Hepatitis A & E References

REFERENCES

Rudolph A, Wang G, Sherman KE, et al. Therapeutic strategies for liver disease. Gastroenterol Hepatol. 2006 Jul;2(7):003-12.
Ryder SD, Beckingham IJ. ABC of diseases of liver, pancreas and biliary system: acute hepatitis. BMJ. 2001 Jan;322(7279):151-153. http://www.ncbi.nlm.nih.gov/. PMID: 11159575
Wedemeyer H, Pischke S, Manns MP. Pathogenesis and treatment of hepatitis E virus infection. Gastroenterology. 2012 May;142(6):1388-1397. http://www.ncbi.nlm.nih.gov/pubmed/22537448. PMID: 22537448
Rutherford AE. Acute viral hepatitis. Merck Manual: Mar 2013. http://www.merckmanuals.com/. Accessed 02 Oct 2013.
National Guideline Clearinghouse. Association for Genitourinary Medicine, Medical Society for the Study of Venereal Disease. Complete summary of 2002 national guideline on the management of viral hepatitides A, B, C. National Guideline Clearinghouse. http://www.guideline.gov.
Umashanker R, Chopra S. Hepatitis E virus infection. UpToDate. http://www.uptodate.com/index. May 2012. Accessed 03 Aug 2012.
College of Paediatrics, Academy of Medicine Malaysia. Malaysian immunisation manual. Academy of Medicine Malaysia. http://www.acadmed.org.my/. 2001.
Cheney CP. Overview of hepatitis A virus infection in adults. UpToDate. http://www.uptodate.com/index. 05 Apr 2012. Accessed 03 Aug 2012.
Wolf DC. Viral hepatitis. eMedicine. http://www.emedicine.com/. 2004.
Lim SG, Aghemo A, Chen PJ, et al. Management of hepatitis C virus infection in the Asia-Pacific region: an update. Lancet Gastroenterol Hepatol. 2017 Jan;2(1):52-62. doi: 10.1016/S2468-1253(16)30080-2. PMID: 28404015
Petruzziello A, Marigliano S, Loquercio G, et al. Global epidemiology of hepatitis C virus infection: an up-date of the distribution and circulation of hepatitis C virus genotypes. World J Gastroenterol. 2016 Sep 14;22(34):7824-7840. doi: 10.3748/wjg.v22.i34.7824. PMID: 27678366
Centers for Disease Control and Prevention. Adult immunization schedule. Recommended immunization schedule for adults aged 19 years or older, by vaccine and age group, United States, 2017. CDC. https://www.cdc.gov/. 06 Feb 2017. Accessed 05 Oct 2017.
British Columbia Centre for Disease Control (BCCDC). Communicable disease control: Hepatitis A. BCCDC. http://www.bccdc.ca/. Dec 2018.
Centers for Disease Control and Prevention. Viral hepatitis: hepatitis A. CDC. https://www.cdc.gov/. Jul 2020.
Centers for Disease Control and Prevention. Viral hepatitis: hepatitis E. CDC. https://www.cdc.gov/. Sep 2020.
Doshani M, Weng M, Moore KL, Romero JR, Nelson NP. Recommendations of the Advisory Committee on Immunization Practices for use of hepatitis A vaccine for persons experiencing homelessness. MMWR Morb Mortal Wkly Rep. 2019 Feb;68(6):153-156. doi: 10.15585/mmwr.mm6806a6. PMID: 30763295
European Association for the Study of the Liver. EASL Clinical Practice Guidelines on hepatitis E virus infection. J Hepatol. 2018 Jun;68(6):1256-1271. doi: 10.1016/j.jhep.2018.03.005. PMID: 29609832
European Centre for Disease Prevention and Control. Hepatitis E. ECDC. https://www.ecdc.europa.eu/. Jun 2017.
Matheny SC, Kingery JE. Hepatitis A. Am Fam Physician. 2012 Dec;86(11):1027-1034. PMID: 23198670
Nelson NP, Link-Gelles R, Hofmeister MG, et al. Update: Recommendations of the Advisory Committee on Immunization Practices for use of hepatitis A vaccine for postexposure prophylaxis and for preexposure prophylaxis for international travel. MMWR Morb Mortal Wkly Rep. 2018 Nov;67(43):1216-1220. doi: 10.15585/mmwr.mm6743a5. PMID: 30383742
Nelson NP, Weng MK, Hofmeister MG, et al. Prevention of hepatitis A virus infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020. MMWR Recomm Rep. 2020 Jul;69(5):1-38. doi: 10.15585/mmwr.rr6905a1. PMID: 32614811
Averhoff F, Vellozzi C. Hepatitis A virus. In: Bennett JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 9th ed. Philadelphia, PA: Elsevier Inc; 2020:2243-2261.e6.
Chopra S, Lai M. Hepatitis A virus infection: Treatment and prevention. UpToDate. https://www.uptodate.com. Oct 2022.
Lai M, Chopra S. Hepatitis A virus infection in adults: Epidemiology, clinical manifestations, and diagnosis. UpToDate. https://www.uptodate.com. Jan 2022.
Trivedi HD, Chopra S. Hepatitis E. In: Bennett JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 9th ed. Philadelphia, PA: Elsevier Inc; 2020:2280-2287.e3.
World Health Organization (WHO). Hepatitis A. WHO. https://apps.who.int/. Jun 2022.
World Health Organization (WHO). Hepatitis E. WHO. https://apps.who.int/. Jun 2022.

Prof. Ghassan Dbaibo, 27 Apr 2023

The WHO defines long COVID as a condition that occurs 3 months from COVID-19 onset, whose symptoms last ≥2 months and cannot be attributed to an alternative diagnosis. In an interview with MIMS Doctor, Professor Ghassan Dbaibo of the Center for Infectious Diseases, American University of Beirut, Beirut, Lebanon, describes the evolving attitudes towards long COVID among healthcare professionals (HCPs), some unexpected predisposing factors, potential biological mechanisms behind prolonged symptom duration and shares data on vaccination’s protective effects against long COVID.

Product Highlight - Ravida

13 Sep 2022

Ravidasvir 200 mg tab

Relationship between tumour response to systemic therapy and overall survival in unresectable hepatocellular carcinoma

Dr Raghav Sundar, 09 Sep 2019

Overall survival (OS) is currently the primary criteria in assessing the efficacy of a cancer treatment. Dr Raghav Sundar, a consultant medical oncologist at the National University Hospital, Singapore, details the crucial role played by tumour response in evaluating treatment efficacy, with a focus on the multiple kinase inhibitor lenvatinib in the treatment of hepatocellular carcinoma (HCC).